Soligenix
SNGX
#10882
Rank
$5.54 M
Marketcap
$0.37
Share price
-0.29%
Change (1 day)
-87.24%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2026 (TTM): -$2.65

According to Soligenix's latest financial reports the company's current EPS (TTM) is -$2.65. In 2025 the company made an earnings per share (EPS) of -$2.14 an increase over its 2024 EPS that were of -$4.98.

EPS history for Soligenix from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$2.6523.83%
2025-$2.14-57.03%
2024-$4.98-60.66%
2023-$12.66-83.55%
2022-$76.9613.95%
2021-$67.54-56.03%
2020-$153.6033.33%
2019-$115.20-29.41%
2018-$163.20-41.38%
2017-$278.4024.73%
2016-$223.20-69%
2015-$720.00-6.25%
2014-$768.00-50.77%
2013-$1,56075.68%
2012-$888.0068.18%
2011-$528.00-69.86%
2010-$1,752-8.75%
2009-$1,92033.33%
2008-$1,440-57.14%
2007-$3,360-46.15%
2006-$6,24044.44%
2005-$4,320-40.7%
2004-$7,285-15.62%
2003-$8,635-25.52%
2002-$11,593-80.94%
2001-$60,821160.89%
2000-$23,313-40.57%
1999-$39,225-63.84%
1998-$108,480601.73%
1997-$15,459101.7%
1996-$7,664

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$8.73-429.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.31-149.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.56-196.59%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-$0.95-64.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$2.03-23.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.37-151.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
-$0.17-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA